S&P 500 component St. Jude Medical Inc. reported its results for the fourth quarter. St. Jude Medical develops, manufactures and distributes cardiovascular medical devices. Results: Net income for the ...

Medical devices major, St. Jude Medical, Inc. (STJ) recently launched its revolutionary MediGuide technology, a three dimensional (“3D”) navigation device used to assist electro-physiologist evaluate ...

St. Jude Medical Inc. (NYSE: STJ) has agreed to pay $90 million in cash for a company that has commercialized an emerging type of medical imaging technology for use during vascular procedures. The ...

Earnings reports are good ways to measure a company’s financial performance. What they’re less useful for is gauging a company’s confidence. You know… Mojo. Swagger. Groove. Minnesota has ...

St. Jude Medical, Inc., said Friday that its defibrillator lead that was removed from a patient in April and reported to be damaged did not have the same critical flaw as an older but similar line of ...

St. Jude Medical announced new features for its Merlin.net remote patient monitoring offering, Patient Care Network (PCN), including mobile alerts for physicians and improved data export to EHRs.

PRESS RELEASE: St. Jude Medical, Inc. a global medical device company, and privately-held CardioMEMS today announced that they have reached an agreement under which St. Jude Medical will make a $60 ...

Little Canada-based St. Jude Medical, Inc., said in a letter to the U.S. Food and Drug Administration (FDA) that it will make a number of improvements to address concerns raised by regulators ...

April 18 (Reuters) - St Jude Medical Inc posted better-than-expected quarterly earnings on Wednesday, but demand for its heart rhythm devices remained sluggish. The medical device maker, which has ...

Having made a habit of defending St. Jude Medical as it navigated its way through a lull in growth, doubts about its clinical pipeline, and the controversy over its Riata leads, it feels a little ...

The FDA sent a warning letter in to St. Jude in 2013, citing problems with the company’s testing of its controversial Durata cardiac device leads. St. Jude Medical Inc. has resolved concerns raised by ...